Class information for:
Level 1: LAROPIPRANT//NIACIN//HM74A

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8325 1195 37.2 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
408 16067 STATINS//EZETIMIBE//SIMVASTATIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LAROPIPRANT Author keyword 113 92% 4% 45
2 NIACIN Author keyword 76 31% 17% 207
3 HM74A Author keyword 64 100% 2% 21
4 GPR109A Author keyword 53 79% 3% 34
5 EXTENDED RELEASE NIACIN Author keyword 31 82% 2% 18
6 NICOTINIC ACID Author keyword 27 19% 10% 123
7 NICOTINIC ACID RECEPTOR Author keyword 24 91% 1% 10
8 PUMA G Author keyword 18 89% 1% 8
9 NICOTINURIC ACID Author keyword 13 80% 1% 8
10 ACIPIMOX Author keyword 11 35% 2% 27

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LAROPIPRANT 113 92% 4% 45 Search LAROPIPRANT Search LAROPIPRANT
2 NIACIN 76 31% 17% 207 Search NIACIN Search NIACIN
3 HM74A 64 100% 2% 21 Search HM74A Search HM74A
4 GPR109A 53 79% 3% 34 Search GPR109A Search GPR109A
5 EXTENDED RELEASE NIACIN 31 82% 2% 18 Search EXTENDED+RELEASE+NIACIN Search EXTENDED+RELEASE+NIACIN
6 NICOTINIC ACID 27 19% 10% 123 Search NICOTINIC+ACID Search NICOTINIC+ACID
7 NICOTINIC ACID RECEPTOR 24 91% 1% 10 Search NICOTINIC+ACID+RECEPTOR Search NICOTINIC+ACID+RECEPTOR
8 PUMA G 18 89% 1% 8 Search PUMA+G Search PUMA+G
9 NICOTINURIC ACID 13 80% 1% 8 Search NICOTINURIC+ACID Search NICOTINURIC+ACID
10 ACIPIMOX 11 35% 2% 27 Search ACIPIMOX Search ACIPIMOX

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PUMA G 123 78% 7% 80
2 NICOTINIC ACID 108 30% 26% 307
3 EXTENDED RELEASE NIACIN 84 40% 14% 163
4 NICOTINIC ACID RECEPTOR 46 67% 4% 42
5 NIACIN 36 27% 10% 114
6 NIASPAN 31 82% 2% 18
7 MK 0524 30 100% 1% 12
8 CORONARY DRUG PROJECT 30 79% 2% 19
9 SUSTAINED RELEASE NIACIN 23 64% 2% 23
10 GPR109A 23 72% 2% 18

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B) 2011 36 110 72%
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis 2010 106 46 43%
Nicotinic acid and derivatives as multifunctional pharmacophores for medical applications 2015 1 59 25%
Nicotinic acid: Pharmacological effects and mechanisms of action 2008 98 87 68%
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review 2005 279 49 53%
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials 2011 21 65 75%
Effects of niacin on glucose control in patients with dyslipidemia 2008 58 38 82%
HEPATIC TOXICITY OF UNMODIFIED AND TIME-RELEASE PREPARATIONS OF NIACIN 1992 71 7 100%
A "Hot" Topic in Dyslipidemia Management-"How to Beat a Flush": Optimizing Niacin Tolerability to Promote Long-term Treatment Adherence and Coronary Disease Prevention 2010 26 123 81%
G protein-coupled receptors for energy metabolites as new therapeutic targets 2012 35 229 39%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 VET AFFAIRS HEALTHCARE SYST 2 20% 0.6% 7
2 CENS EUROPEAN NUTR SAFETY HLTH 1 100% 0.2% 2
3 VIS SCI DISCOVERY 1 100% 0.2% 2
4 NW LIPID CLIN 1 18% 0.4% 5
5 BOSHELL DIABET METAB DIS PROGRAM 1 25% 0.3% 3
6 ALBANY STRATTON VA MED 1 50% 0.1% 1
7 BERKELEY HEART 1 50% 0.1% 1
8 BRB 2 3 S 654 1 50% 0.1% 1
9 CARMEN INRA 1235 1 50% 0.1% 1
10 CHEMPHARM CMC SCI DOSSIER MANAGEMENT 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000153610 TORCETRAPIB//HIGH DENSITY LIPOPROTEIN//ANACETRAPIB
2 0.0000136281 STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN
3 0.0000131884 PRAVASTATIN//HMG COA REDUCTASE INHIBITOR//COMPACTIN
4 0.0000125574 FENOFIBRIC ACID//FENOFIBRATE//FIBRATES
5 0.0000098393 EZETIMIBE//CHOLESTEROL ABSORPTION INHIBITOR//COLESEVELAM
6 0.0000075991 MICROPOPULATION//MICROPOPULATION MODEL//EXPONENTIAL RISK AVOIDANCE MODELS
7 0.0000069149 GRADIENT GEL ELECTROPHORESIS//SMALL DENSE LDL//FAMILIAL COMBINED HYPERLIPIDEMIA
8 0.0000063139 PROBUCOL//AGI 1067//SUCCINOBUCOL
9 0.0000056648 PARTIAL ILEAL BYPASS//POSCH//ATHEROGENIC RATIO
10 0.0000054865 FUMARIC ACID ESTERS//DIMETHYL FUMARATE//DIMETHYLFUMARATE